Ronald Eibensteiner

Director at Reprise Biomedical.

Plymouth, MN
Reprise Biomedical

Raised on Reprise Biomedical filings

$9.2M

of $10M offered across 2 Form D filings

Form D filings: 2
Teammates: 12
Last filing: Jul 1, 2026

Company

Reprise Biomedical

Biotech · Plymouth, MN

Pig liver collagen scaffolds for deep wounds

Pig liver collagen scaffolds for deep wounds

Investors: 4
Still open: $754K

Investors: 4
Sector: Biotech
HQ: Plymouth, MN

Reprise Biomedical filings

Reprise Biomedical Form D filings
Filed	Security	Sold of offered	Filing
Jul 1, 2026	Equity	$9.2M/ $10M	Form D/A
May 21, 2026	Equity	$1.4M/ $8M	Form D

EquityFiled Jul 1, 2026Form D/A
$9.2M/ $10M
EquityFiled May 21, 2026Form D
$1.4M/ $8M

Works with

Also named on Reprise Biomedical filings

Carrie PowersChief Executive Officer, Form D signerForm D signer Jeff DuncanExecutive Officer Alan WoldtDirector Erwin KelenDirector Greg SmockExecutive Officer Heather KotilaExecutive Officer Howard RootDirector Jake IsenburgExecutive Officer Jerrod KruegerExecutive Officer Phil NalboneDirector Steve JagodzinskiExecutive Officer Tom KouchoukosExecutive Officer